{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:21:37Z","timestamp":1792315297053,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T00:00:00Z","timestamp":1410393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00277-014-2207-9","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T02:52:09Z","timestamp":1410317529000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage"],"prefix":"10.1007","volume":"94","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Eisenwort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mannhalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bettelheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Arock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,11]]},"reference":[{"issue":"5","key":"2207_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","volume":"122","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR et al (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122(5):695\u2013717","journal-title":"Br J Haematol"},{"issue":"2","key":"2207_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","volume":"74","author":"HP Horny","year":"2007","unstructured":"Horny HP, Sotlar K, Valent P (2007) Mastocytosis: state of the art. Pathobiology 74(2):121\u2013132","journal-title":"Pathobiology"},{"issue":"4","key":"2207_CR3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112(4):946\u2013956","journal-title":"Blood"},{"issue":"4","key":"2207_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/ehm.10.42","volume":"3","author":"M Arock","year":"2010","unstructured":"Arock M, Valent P (2010) Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 3(4):497\u2013516","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"2207_CR5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25(7):603\u2013625","journal-title":"Leuk Res"},{"key":"2207_CR6","first-page":"291","volume-title":"World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues","author":"P Valent","year":"2001","unstructured":"Valent P, Horny H-P, Li CY et al (2001) Mastocytosis (mast cell disease). In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press Lyon, France, pp 291\u2013302"},{"key":"2207_CR7","first-page":"54","volume-title":"Tumours of haematopoietic and lymphoid tissues","author":"HP Horny","year":"2008","unstructured":"Horny HP, Akin C, Metcalfe DD et al (2008) Mastocytosis (mast cell disease). In: World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, France, pp 54\u201363"},{"issue":"12","key":"2207_CR8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","volume":"61","author":"WD Travis","year":"1986","unstructured":"Travis WD, Li CY, Hoagland HC et al (1986) Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 61(12):957\u2013966","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"2207_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","volume":"27","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR et al (2003) Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 27(7):635\u2013641","journal-title":"Leuk Res"},{"issue":"8","key":"2207_CR10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","volume":"121","author":"S Georgin-Lavialle","year":"2013","unstructured":"Georgin-Lavialle S, Lhermitte L, Dubreuil P et al (2013) Mast cell leukemia. Blood 121(8):1285\u20131295","journal-title":"Blood"},{"issue":"8","key":"2207_CR11","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","volume":"106","author":"J Gotlib","year":"2005","unstructured":"Gotlib J, Berub\u00e9 C, Growney JD et al (2005) Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 106(8):2865\u20132870","journal-title":"Blood"},{"issue":"12","key":"2207_CR12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.21561","volume":"84","author":"KH Lim","year":"2009","unstructured":"Lim KH, Pardanani A, Butterfield JH et al (2009) Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol 84(12):790\u2013794","journal-title":"Am J Hematol"},{"issue":"18","key":"2207_CR13","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","volume":"114","author":"A Pardanani","year":"2009","unstructured":"Pardanani A, Lim KH, Lasho TL et al (2009) Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood 114(18):3769\u20133772","journal-title":"Blood"},{"issue":"5","key":"2207_CR14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12185-008-0166-4","volume":"88","author":"L Pagano","year":"2008","unstructured":"Pagano L, Valentini CG, Caira M et al (2008) Advanced mast cell disease: an Italian Hematological Multicenter experience. Int J Hematol 88(5):483\u2013488","journal-title":"Int J Hematol"},{"key":"2207_CR15","doi-asserted-by":"crossref","unstructured":"Valent P, Sotlar K, Sperr WR et al. (2014) Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann Oncol 25(9):1691\u20131700","DOI":"10.1093\/annonc\/mdu047"},{"issue":"6","key":"2207_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37(6):435\u2013453","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2207_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","volume":"58","author":"L Escribano","year":"2004","unstructured":"Escribano L, Diaz-Agustin B, L\u00f3pez A et al (2004) Spanish Network on Mastocytosis (REMA). Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 58(1):1\u20138","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"2207_CR18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","volume":"162","author":"K Sotlar","year":"2003","unstructured":"Sotlar K, Escribano L, Landt O et al (2003) One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 162(3):737\u2013746","journal-title":"Am J Pathol"},{"issue":"7","key":"2207_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","volume":"25","author":"WR Sperr","year":"2001","unstructured":"Sperr WR, Escribano L, Jordan JH et al (2001) Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 25(7):529\u2013536","journal-title":"Leuk Res"},{"issue":"7","key":"2207_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","volume":"25","author":"HP Horny","year":"2001","unstructured":"Horny HP, Valent P (2001) Diagnosis of mastocytosis: general histopathological aspects, morphological criteria and immunohistochemical findings. Leuk Res 25(7):543\u2013551","journal-title":"Leuk Res"},{"issue":"9","key":"2207_CR21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","volume":"22","author":"HP Horny","year":"1998","unstructured":"Horny HP, Sillaber C, Menke D et al (1998) Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 22(9):1132\u20131140","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2207_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","volume":"113","author":"R Fritsche-Polanz","year":"2001","unstructured":"Fritsche-Polanz R, Jordan JH, Feix A et al (2001) Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 113(2):357\u2013364","journal-title":"Br J Haematol"},{"key":"2207_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-62703-357-2_4","volume":"999","author":"K Sotlar","year":"2013","unstructured":"Sotlar K (2013) c-kit mutational analysis in paraffin material. Methods Mol Biol 999:59\u201378","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2207_CR24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","volume":"107","author":"KV Gleixner","year":"2006","unstructured":"Gleixner KV, Mayerhofer M, Aichberger KJ et al (2006) PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 107(2):752\u2013759","journal-title":"Blood"},{"issue":"5","key":"2207_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3324\/haematol.2010.031328","volume":"96","author":"B Peter","year":"2011","unstructured":"Peter B, Gleixner KV, Cerny-Reiterer S et al (2011) Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. Haematologica 96(5):672\u2013680","journal-title":"Haematologica"},{"issue":"4","key":"2207_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","volume":"24","author":"K Sotlar","year":"2011","unstructured":"Sotlar K, Cerny-Reiterer S, Petat-Dutter K et al (2011) Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 24(4):585\u2013595","journal-title":"Mod Pathol"},{"issue":"23","key":"2207_CR27","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK et al (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A 92(23):10560\u201310564","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2207_CR28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","volume":"12","author":"BJ Longley","year":"1996","unstructured":"Longley BJ, Tyrrell L, Lu SZ et al (1996) Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12(3):312\u2013314","journal-title":"Nat Genet"},{"issue":"2","key":"2207_CR29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","volume":"127","author":"F F\u00e9ger","year":"2002","unstructured":"F\u00e9ger F, Ribadeau Dumas A et al (2002) Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 127(2):110\u2013114","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"2207_CR30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","volume":"130","author":"C Bodemer","year":"2010","unstructured":"Bodemer C, Hermine O, Palm\u00e9rini F et al (2010) Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 130(3):804\u2013815","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2207_CR31","first-page":"8","volume":"3","author":"P Valent","year":"2013","unstructured":"Valent P, Blatt K, Eisenwort G et al (2013) FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H. Leuk Res Rep 3(1):8\u201313","journal-title":"Leuk Res Rep"},{"issue":"7","key":"2207_CR32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","volume":"116","author":"Y Yang","year":"2010","unstructured":"Yang Y, L\u00e9tard S, Borge L et al (2010) Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 116(7):1114\u20131123","journal-title":"Blood"},{"issue":"23\u201324","key":"2207_CR33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00508-012-0293-z","volume":"124","author":"P Valent","year":"2012","unstructured":"Valent P, Arock M, Bonadonna P et al (2012) European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr 124(23\u201324):807\u2013814","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"2207_CR34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","volume":"30","author":"L Escribano","year":"1997","unstructured":"Escribano L, Orfao A, Villarrubia J et al (1997) Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30(2):98\u2013102","journal-title":"Cytometry"},{"issue":"8","key":"2207_CR35","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","volume":"91","author":"L Escribano","year":"1998","unstructured":"Escribano L, Orfao A, D\u00edaz-Agustin B et al (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91(8):2731\u20132736","journal-title":"Blood"},{"issue":"4","key":"2207_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2012.12.674","volume":"131","author":"C Teodosio","year":"2013","unstructured":"Teodosio C, Garc\u00eda-Montero AC, Jara-Acevedo M et al (2013) Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis. J Allergy Clin Immunol 131(4):1213\u20131224","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR37","doi-asserted-by":"crossref","unstructured":"Hoermann G, Blatt K, Greiner G et al. (2014) CD52 is a molecular target in advanced systemic mastocytosis. FASEB J 28(8):3540\u20133551","DOI":"10.1096\/fj.14-250894"},{"issue":"13","key":"2207_CR38","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","volume":"98","author":"GH Schernthaner","year":"2001","unstructured":"Schernthaner GH, Jordan JH, Ghannadan M et al (2001) Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood 98(13):3784\u20133792","journal-title":"Blood"},{"issue":"5","key":"2207_CR39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/10428194.2010.550072","volume":"52","author":"P Valent","year":"2011","unstructured":"Valent P, Sotlar K, Horny HP (2011) Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms. Leuk Lymphoma 52(5):740\u2013744","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2207_CR40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","volume":"63","author":"JM Morgado","year":"2013","unstructured":"Morgado JM, Perbellini O, Johnson RC et al (2013) CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology 63(6):780\u2013787","journal-title":"Histopathology"},{"issue":"14","key":"2207_CR41","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","volume":"122","author":"J Schwaab","year":"2013","unstructured":"Schwaab J, Schnittger S, Sotlar K et al (2013) Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 122(14):2460\u20132466","journal-title":"Blood"},{"issue":"1","key":"2207_CR42","doi-asserted-by":"crossref","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","volume":"9","author":"G Damaj","year":"2014","unstructured":"Damaj G, Joris M, Chandesris O et al (2014) ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. PLoS ONE 9(1):e85362","journal-title":"PLoS ONE"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2207-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2207-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T06:44:48Z","timestamp":1598251488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2207-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2207-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,11]]}}}